At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
LENZ Therapeutics
Closed Good Friday 04-17 16:00:00 EDT
23.82
+0.76
+3.30%
盘后25.01
+1.19+5.00%
19:38 EDT
| High24.59 | Low23.01 | Vol218.56K |
| Open23.03 | D1 Closing23.06 | Amplitude6.83% |
| Mkt Cap656.07M | Tradable Cap267.04M | Total Shares27.54M |
| T/O5.26M | T/O Rate1.95% | Tradable Shares11.21M |
| P/B-- | ROE-- | EPS0.00 |
| 52wk High-- | 52wk Low-- | P/E-- |
| Dividend-- | Div.Yield-- | ROA-- |
Loading ...
JPMorgan says Lilly data ‘highly favorable’ for Structure Therapeutics
TipRanks · 14:26
Director Makes Bold Move with Major Stock Purchase in Guided Therapeutics!
TIPRANKS · 02:02
BofA Adjusts Price Target on Springworks Therapeutics to $84 From $87, Keeps Buy Rating
MT Newswires Live · 04-17 15:21
BofA Adjusts Price Target on CRISPR Therapeutics to $80 From $86, Keeps Buy Rating
MT Newswires Live · 04-17 15:21
Design Therapeutics Names Chris Storgard as Chief Medical Officer
MT Newswires Live · 04-17 14:27
Press Release: Werewolf Therapeutics Appoints Steven Bloom as Chief Business Officer
Dow Jones · 04-17 12:00
Press Release: Design Therapeutics Appoints Veteran Industry Executive Chris Storgard, M.D., as Chief Medical Officer
Dow Jones · 04-17 12:00
Ligand to Combine Pelthos Unit With Channel Therapeutics
Dow Jones · 04-17 11:31
Bright Peak Therapeutics Appoints John Schmid to its Board of Directors
GlobeNewswire · 04-17 11:00
Ligand Pharmaceuticals to Merge Units With Channel Therapeutics to Launch Pelthos Therapeutics
MT Newswires Live · 04-17 10:37
Ligand Subsidiary Pelthos Therapeutics to Combine with Channel Therapeutics
GlobeNewswire · 04-17 10:00
EXCLUSIVE: Ligand Subsidiary Pelthos Therapeutics To Combine with Channel Therapeutics Creating Pain Medicines Focused Entity
Benzinga · 04-17 09:45
Neurizon Therapeutics Makes Three Executive Appointments; Shares Up 15%
MT Newswires Live · 04-17 05:25
Prescient Therapeutics Receives Fast Track FDA Designation for Potential Lymphoma Treatment; Shares Up 5%
MT Newswires Live · 04-17 04:18
Alterity Therapeutics Announces New Options Prospectus to Bolster Financial Strategy
TIPRANKS · 04-17 04:02
Prescient Therapeutics Advances Cancer Therapy with FDA Fast Track
TIPRANKS · 04-17 03:02
Zydus Lifesciences' Venture Capital Arm Invests in Canada's Feldan Therapeutics
MT Newswires Live · 04-17 02:49
Neurizon Therapeutics Bolsters Leadership Team with Strategic Appointments
TIPRANKS · 04-17 01:17
Allarity Therapeutics Restructures Board of Directors
TIPRANKS · 04-16 20:30
BriaCell Therapeutics Stock Rises on Data for Late Stage Breast Cancer Treatment
Dow Jones · 04-16 17:32
Introduction
Company Name.
Therapeutics
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
LENZ Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies to improve vision in the United States. Its product candidates include LNZ100 and LNZ101 which are in Phase III clinical trials for the treatment of presbyopia. The company is headquartered in Del Mar, California.
Issue price:
--
Invest in Global Markets with Tiger Brokers!Open App